HIGHLIGHTS
- who: Guilherme Lepski and colleagues from the Laboratory of Experimental Surgery (LIM26), Hospital das Clu00ednicas, Medical School, Universidade Su00e3o Paulo, Su00e3o Paulo, Brazil have published the article: Adjuvant Vaccination with Allogenic Dendritic Cells Significantly Prolongs Overall Survival in High-Grade Gliomas: Results of a Phase II Trial, in the Journal: Cancers 2023, 15, 1239. of /2023/
- what: The authors report the results of a phase I/II prospective non-controlled clinical trial with 37 patients harboring glioblastoma or grade 4 astrocytomas.
SUMMARY
The current DC-vaccination trial included 37 patients with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.